-
公开(公告)号:AU2009238590A1
公开(公告)日:2009-10-29
申请号:AU2009238590
申请日:2009-04-22
Applicant: PORTOLA PHARM INC
Inventor: MEHROTRA MUKUND , PANDEY ANJALI , SONG YONGHONG , JIA ZHAOZHONG J , XU QING , BAUER SHAWN M
IPC: C07D239/48 , A61K31/506 , A61K31/52 , A61P9/00 , A61P29/00 , A61P35/00 , C07D401/04 , C07D401/14 , C07D403/04 , C07D471/04 , C07D473/16
-
公开(公告)号:CA2728893C
公开(公告)日:2017-03-14
申请号:CA2728893
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , JIA ZHAOZHONG J , ROSE JACK W
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: The present invention is directed to compounds of formula I-V and tautomers thereof or pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods ofinhibilion the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as cardiovascular disease, inflammatory disease and autoimune disease and cell proliferative disorder. Formula (I) Y1 is selected from the group consisting of: (a) and (b); Z is O or S; D1 is selected from the group consisting of: (a) phenyl substituted with a group, R5 (b) naphthyl (c) C3-8cycloalkyl (d) heteroaryl (e) heterocyclyl
-
公开(公告)号:HRP20161310T1
公开(公告)日:2016-12-02
申请号:HRP20161310
申请日:2016-10-11
Applicant: PORTOLA PHARM INC
Inventor: BAUER SHAWN M , JIA ZHAOZHONG J , SONG YONGHONG , XU QING , MEHROTRA MUKUND , ROSE JACK W , HUANG WOLIN , VENKATARAMANI CHANDRASEKAR , PANDEY ANJALI
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D413/12 , C07D417/12
-
公开(公告)号:AU2011323484B2
公开(公告)日:2016-10-06
申请号:AU2011323484
申请日:2011-11-01
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , SONG YONGHONG , XU QING , KANE BRIAN , BAUER SHAWN M , PANDEY ANJALI
IPC: C07D213/82 , A61K31/455 , A61P35/00 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D495/04
Abstract: The present invention is directed to compounds of formula I and pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of Syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition Syk kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by Syk kinase activity, such as Non Hodgkin's Lymphoma.
-
公开(公告)号:HK1209316A1
公开(公告)日:2016-04-01
申请号:HK15109941
申请日:2015-10-12
Applicant: PORTOLA PHARM INC
Inventor: SONG YONGHONG , XU QING , SRAN ARVINDER , BAUER SHAWN M , JIA ZHAOZHONG J , KANE BRIAN , PANDEY ANJALI
IPC: A61K20060101
-
公开(公告)号:ES2546502T3
公开(公告)日:2015-09-24
申请号:ES09742982
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , ROSE JACK W
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: Un compuesto que tiene la fórmula (I):**Fórmula** o uno de sus tautómeros o sales farmacéuticamente aceptables, en donde: D1 es fenilo sustituido con heteroarilo; cada E1 está seleccionado de modo independiente del grupo que consiste en alquilo C1-8, alquenilo C2-8, alquinilo C2-8, alcoxi C1-8, alquil C1-8-tio, aminocarbonilo, alcoxi C1-8-carbonil-alquileno C1-8, alcoxi C1-8-carbonil C1-8alcoxi C1-8, alcoxi C1-8-carbonilamino, oxo, halo, ciano, haloalquilo C1-8, haloalcoxi C1-8, aminosulfonilo, heteroarilsulfinilo; amino, hidroxilo, arilalquileno C1-8, fenilo, aminoalquilo C1-8, aminocicloalquilo C3-8, heterociclilo, heteroarilo, acilo C1-8, alquil C1-8 sulfonilo, acilamino y heterociclilalquileno C1-8; el subíndice n es 0, 1, 2, 3 ó 4; el resto:**Fórmula** es bien: (a)**Fórmula** y donde X e Y están seleccionados independientemente del grupo que consiste en: CH2, NH, NCOOH3 y S; (b) seleccionado del grupo que consiste en:**Fórmula** y donde cada R8a y R8b es independientemente H, hidroxilo, halo o si están en carbonos adyacentes, pueden combinarse con los átomos a los que están unidos para formar un anillo de benceno fusionado; y cada R9a y R9b es independientemente H, hidroxilo, halo o si están en carbonos adyacentes, pueden combinarse con los átomos a los que están unidos para formar un anillo de benceno fusionado; y la línea ondulada indica el punto de unión al resto de la molécula; o**Fórmula** (c) donde cada R8a y R8b es independientemente H o pueden combinarse con los átomos a los que están unidos para formar un anillo de benceno fusionado; y la línea ondulada indica el punto de unión al resto de la molécula; y "cicloalquilo" se refiere a un grupo hidrocarbonado mono o policíclico alifático, que puede formar un anillo con puente o un anillo espiro, y que puede tener uno o más enlaces dobles o triples.
-
公开(公告)号:AU2009244897B2
公开(公告)日:2014-11-13
申请号:AU2009244897
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: MEHROTRA MUKUND , HUANG WOLIN , SONG YONGHONG , JIA ZHAOZHONG J , XU QING , VENKATARAMANI CHANDRASEKAR , BAUER SHAWN M , PANDEY ANJALI , ROSE JACK , KANE BRIAN
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: The present invention is directed to compounds of formula I-V and tautomers thereof or pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods ofinhibilion the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as cardiovascular disease, inflammatory disease and autoimmune disease and cell proliferative disorder. Formula (I) Y
-
公开(公告)号:EA019973B1
公开(公告)日:2014-07-30
申请号:EA201001618
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , ROSE JACK W
IPC: C07D239/48 , A61K31/506 , A61P9/00 , A61P35/00 , C07D401/12 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12
Abstract: Изобретениенаправленонасоединенияформул I-V иихтаутомерыилиихфармацевтическиприемлемыесоли, сложныеэфирыи пролекарства, которыеявляютсяингибиторамикиназы Syk. Изобретениетакженаправленонапромежуточныесоединения, используемыедляполучениятакихсоединений, получениетакихсоединений, фармацевтическиекомпозиции, содержащиетакиесоединения, способыингибированияактивности Syk-киназы, способыингибированияагрегациитромбоцитов, испособыпредотвращенияилилечениярядасостояний, опосредованных, поменьшеймере, частичноактивностью Syk-киназы, такойкакнежелательныйтромбозози неходжкинскаялимфома.
-
公开(公告)号:CO6990735A2
公开(公告)日:2014-07-10
申请号:CO14135724
申请日:2014-06-24
Applicant: PORTOLA PHARM INC
Inventor: SONG YONGHONG , XU QING , JIA ZHAOZHONG J , KANE BRIAN , BAUER SHAWN M , PANDEY ANJALI
IPC: A61K31/4965
-
公开(公告)号:SG2014015085A
公开(公告)日:2014-06-27
申请号:SG2014015085
申请日:2009-04-16
Applicant: PORTOLA PHARM INC
Inventor: JIA ZHAOZHONG J , VENKATARAMANI CHANDRASEKAR , HUANG WOLIN , MEHROTRA MUKUND , SONG YONGHONG , XU QING , BAUER SHAWN M , PANDEY ANJALI , KANE BRIAN , ROSE JACK W
-
-
-
-
-
-
-
-
-